Selected article for: "informed consent and real time"
Author: Xiaolong Qi; Zicheng Jiang; QIAN YU; Chuxiao Shao; Hongguang Zhang; Hongmei Yue; Baoyi Ma; Yuancheng Wang; Chuan Liu; Xiangpan Meng; Shan Huang; Jitao Wang; Dan Xu; Junqiang Lei; Guanghang Xie; Huihong Huang; Jie Yang; Jiansong Ji; Hongqiu Pan; Shengqiang Zou; Shenghong Ju
Title: Machine learning-based CT radiomics model for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: A multicenter study
  • Document date: 2020_3_3
    • ID: 2s4ifz7i_21
    Snippet: The multicenter study was conducted according to principles of the Declaration of Helsinki and approved by all institutional review board. The need for written informed consent from the participants was waived. Patients with laboratory-confirmed SARS-CoV-2 infection and their initial CT images were enrolled from 5 designated hospitals between January 23, 2020 and February 8, 2020, with final follow-up on February 20, 2020 (Figure 1 ). Most patien.....
    Document: The multicenter study was conducted according to principles of the Declaration of Helsinki and approved by all institutional review board. The need for written informed consent from the participants was waived. Patients with laboratory-confirmed SARS-CoV-2 infection and their initial CT images were enrolled from 5 designated hospitals between January 23, 2020 and February 8, 2020, with final follow-up on February 20, 2020 (Figure 1 ). Most patients received antiviral treatment with interferon inhalation, lopinavir and ritonavir, combined with probiotics. Patients were discharged once the results of two real-time fluorescence polymerase-chain-reaction tests taken 24 hours apart were negative for SARS-CoV-2 antigens. Patients without pneumonia findings or those remained in hospital were excluded.

    Search related documents:
    Co phrase search for related documents
    • antiviral treatment and CT image: 1, 2
    • antiviral treatment and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral treatment and interferon inhalation: 1, 2, 3, 4, 5
    • antiviral treatment and laboratory confirm: 1
    • antiviral treatment and multicenter study: 1, 2, 3, 4, 5, 6, 7, 8
    • antiviral treatment and participant informed consent: 1, 2, 3
    • antiviral treatment and patient antiviral treatment receive: 1, 2
    • antiviral treatment receive and chain reaction: 1, 2
    • antiviral treatment receive and informed consent: 1
    • antiviral treatment receive and patient antiviral treatment receive: 1, 2
    • chain reaction and CT image: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and fluorescence polymerase chain reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and fluorescence polymerase chain reaction test: 1, 2, 3, 4, 5, 6, 7
    • chain reaction and hospital remain: 1
    • chain reaction and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and initial CT image: 1
    • chain reaction and interferon inhalation: 1, 2, 3
    • chain reaction and laboratory confirm: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • chain reaction and multicenter study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25